CrossrefInfokarte
PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Pharmacogenomics and Personalized Medicine · 2024-12 · Volume 17 · 611-621
DOI: 10.2147/pgpm.s490030 ↗Abstract
Kein Abstract verfügbar.
EUVIMED